Concurrently with the execution of the BCA Amendment, parties to
the Shareholder Support Agreement entered into a deed of amendment
to the Shareholder Support Agreement (the “Amendment to Shareholder
Support Agreement”), which provides, among other things, that (i)
the period during which Mr. Yeung is contractually restricted from
transferring or otherwise disposing of 50% of the equity securities
of PubCo acquired by him in the Acquisition Merger by virtue of
holding equity securities of Prenetics is reduced from one year
after the closing of Acquisition Merger to 6 months after the
closing of Acquisition Merger; and (ii) the period during which Mr.
Yeung is contractually restricted from transferring or otherwise
disposing of the remaining 50% of the equity securities of PubCo
acquired by him in the Acquisition Merger by virtue of holding
equity securities of Prenetics is reduced from 18 months after the
closing of Acquisition Merger to 12 months after the closing of
Acquisition Merger, in each case subject to earlier release if
certain criteria are met.
Assignment, Assumption and Amendment
Agreement
Concurrently with the execution of the BCA, Artisan, PubCo and
Continental Stock Transfer & Trust Company (“Continental”)
entered into an amendment (the “Assignment, Assumption and
Amendment Agreement”) to that certain warrant agreement, dated May
13, 2021, by and between Artisan and Continental (the “Existing
Warrant Agreement”), to be effective upon closing pursuant to
which, among other things, Artisan will agree to assign all of its
right, title and interest in the Existing Warrant Agreement to
PubCo.
Results of Operations
We have neither engaged in any operations nor generated any
revenues to date. Our only activities for the three months ended
March 31, 2022 and for the period from February 2, 2021 (inception)
through December 31, 2021 were organizational activities, those
necessary to prepare for our initial public offering, described
below, and, after our initial public offering, identifying a target
company for a business combination. We do not expect to generate
any operating revenues until after the completion of our initial
business combination. We generate non-operating income in the form
of interest income on investments held in our trust account after
the initial public offering. We incur expenses as a result of being
a public company (for legal, financial reporting, accounting and
auditing compliance), as well as for due diligence expenses.
For the three months ended March 31, 2022, we had net income of
$7,191,614, which resulted from a change in the fair value of
warrant liabilities of $7,638,850, a change in fair value of the
forward purchase agreement derivative liability of $794,463, and
the unrealized gain on investments held in the trust account of
$28,395, partially offset by formation and operating costs of
$1,270,094.
For the period from February 2, 2021 (inception) through March 31,
2021, we had a net loss of $5,500, which resulted fully from
formation and operating costs.
Liquidity and Capital Resources
For the three months ended March 31, 2022, net cash used in
operating activities was $104,872, which was due to the change in
the fair value of warrant liabilities of $7,638,850, the change in
fair value of the forward purchase agreement derivative liability
of $794,463, and unrealized gain on investments held in the trust
account of $28,395, partially offset by our net income of
$7,191,614 and changes in working capital accounts of
$1,165,222.
For the period from February 2, 2021 (inception) through March 31,
2021, net cash used in operating activities was $0, which was
due to our net loss of $5,500, offset by the change in accrued
expenses of $5,500.
Net cash provided by financing activities for the for the three
months ended March 31, 2022 of $14,810 was comprised of $13,130 in
proceeds from the promissory note – related party and $1,680 in
proceeds from the advance from related party.
On May 18, 2021, we consummated our initial public offering of
30,000,000 units. Each unit consists of one share of one Class A
ordinary share of the Company, par value $0.0001 per share and
one-third of one redeemable warrant of the Company, with each whole
warrant entitling the holder thereof to purchase one Class A
ordinary shares for $11.50 per share. The units were sold at a
price of $10.00 per unit, generating gross proceeds to the Company
of $300,000,000. The Company granted the underwriters a 45-day
option to purchase up to 4,500,000 additional units solely to cover
over-allotments.